Heart Disease in Women: Unappreciated Challenges, GPER as a New Target.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic reasoning and prior observational findings
PubMed 27213340 · doi:10.3390/ijms17050760
What was done
This narrative review describes the clinical challenges of heart disease in women, the biological basis for postmenopausal atherosclerotic risk, and evidence on the role of the G protein-coupled estrogen receptor (GPER) and its genetic variants in blood pressure and low-density lipoprotein (LDL) receptor regulation.
What was found
No quantitative data, sample sizes, or numerical effect sizes are reported in the abstract. The authors report qualitatively that GPER activation regulates blood pressure and LDL receptor metabolism, and that expression of a hypofunctional GPER variant contributes to hypertension and hypercholesterolemia, predominantly in women.
Why it matters
It highlights GPER signaling as a potential biological mechanism and therapeutic target underlying sex-specific cardiovascular risk in postmenopausal women.
Limits
As a narrative review, it lacks a systematic search strategy, quality appraisal, and meta-analytic synthesis. The abstract provides no specific numbers, effect sizes, or participant counts.
Cited by
- contradicts Cholesterol levels rise in perimenopause because the liver continues producing cholesterol to synthesize steroid hormones after the ovaries stop responding.